On Invalid Date, Mira Pharmaceuticals (NASDAQ: MIRA) reported Q4 2023 earnings per share (EPS) of -$0.19, up 733.33% year over year. Total Mira Pharmaceuticals earnings for the quarter were -$5.79 million. In the same quarter last year, Mira Pharmaceuticals's earnings per share (EPS) was $0.03.
As of Q2 2024, Mira Pharmaceuticals's earnings has grown year over year. Mira Pharmaceuticals's earnings in the past year totalled -$11.98 million.
What was MIRA's revenue last quarter?
On Invalid Date, Mira Pharmaceuticals (NASDAQ: MIRA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mira Pharmaceuticals's revenue was $0.00.
What was MIRA's revenue growth in the past year?
As of Q2 2024, Mira Pharmaceuticals's revenue has grown null year over year. Mira Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.